VMI
ORTX

VHCP Management III’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

VHCP Management III’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-67,625
Closed -$9.46M – 19
2019
Q2 		$9.46M Sell
67,625
-13,478
-17% -$2.37M 4.42% 10
2019
Q1 		$14.5M Sell
81,103
-23,049
-22% -$3.46M 8.45% 6
2018
Q4 		$16.4M Buy
+104,152
New +$15.5M 11.91% 3

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

VHCP Management III's ORTX Position: Q3 2019 in Review

VHCP Management III sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2019, closing a stake of 67,625 shares — an estimated $9.46M sold.

VHCP Management III first reported a position in ORTX in Q4 2018 and held it in 3 quarters. The position peaked at $16.4M in Q4 2018. 62 funds tracked by Wall St. Rank hold ORTX as of Q3 2019.

  • VHCP Management III reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • VHCP Management III sold 67,625 Orchard Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $9.46M.
  • VHCP Management III first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 3 quarters.
  • VHCP Management III's Orchard Therapeutics plc American Depositary Shares position peaked at $16.4M in Q4 2018.
  • 62 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2019.

Based on VHCP Management III's 13F filing for Q3 2019, filed 13 Nov 2019.